Onasemnogene abeparvovec preserves bulbar function in infants with presymptomatic spinal muscular atrophy: a post-hoc analysis of the SPR1NT trial

Richard D. Shell, Katlyn E. McGrattan, Rebecca Hurst-Davis, Sally Dunaway Young, Giovanni Baranello, Arseniy Lavrov, Eamonn O'Brien, Shiri Wallach, Nicole LaMarca, Sandra P. Reyna, Basil T. Darras

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Onasemnogene abeparvovec preserves bulbar function in infants with presymptomatic spinal muscular atrophy: a post-hoc analysis of the SPR1NT trial'. Together they form a unique fingerprint.

Medicine & Life Sciences